Effect of ranitidine and metronidazole on 1gG activity of patients with Helicobacter pylori infection.
Konorev
M R
MR
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D017151:Antibodies, Catalytic / Q000032:analysis*; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000201:enzymology; D016480:Helicobacter pylori; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D011899:Ranitidine / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D000907:Antibodies, Bacterial; D017151:Antibodies, Catalytic; D007074:Immunoglobulin G; D008795:Metronidazole; D011899:Ranitidine